Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Alzheimer's disease (AD) is a complex neurodegenerative disorder, and current therapies mainly offer symptomatic relief. Given that the pathophysiology of AD is multifaceted, a multimodal therapeutic strategy targeting multiple molecular pathways implicated in AD-related pathogenesis represents a pragmatic avenue for impeding the advancement of AD. In this study, we evaluated the anti-Alzheimer effects of an HDAC6 inhibitor WY118, both alone and in combination with lithium chloride (LiCl), a GSK-3β inhibitor, to synergistically suppress ferroptosis. The combination of compound WY118 and LiCl demonstrated significant synergistic effects in both cellular models of AD induced by glutamate and streptozotocin. The findings suggest that compound WY118, in particular in combination with LiCl, exhibits potent anti-Alzheimer effects by synergistically suppressing ferroptosis. Studies on the mechanism of action indicated that the combination treatment significantly reduced tau phosphorylation and inhibited p38 MAPK signaling. This combination therapy holds promise for developing more effective treatments for AD.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ejphar.2025.177605 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Natural Products, Synthesis, and Biological Activities of Quinolines (2020-2024).
Mini Rev Med Chem
August 2025
Department of Chemistry and Chemical Engineering, SBASSE, Lahore University of Management Sciences (LUMS), DHA, Lahore, 54792, Pakistan.
Quinoline is a biologically important bicyclic scaffold found in many natural products and medicinally relevant molecules. Quinoline-containing compounds continue to feature prominently in recent literature on hit identification and hit-to-lead campaigns targeting various biological pathways, underscoring the need for a review of the latest progress. This review presents recently reported quinoline-containing natural products, various synthetic methods for producing quinoline derivatives, and an overview of their diverse biological activities.
View Article and Find Full Text PDFCurrent Developments in the Pharmacological Activities and Synthesis of Carbazole Derivatives.
Mini Rev Med Chem
September 2025
Adarsh Vijendra Institute of Pharmaceutical Sciences, Shobhit University, Gangoh, Saharanpur, 247341, India.
The growing prevalence of multidrug resistance and its detrimental effects pose a significant threat to public health, which is one reason for the current interest in the introduction of novel agents. To combat this adverse effect and drug resistance, numerous drugs have been developed over time, and their safety is still being evaluated; derivatives or medications based on the carbazole moiety are one of the key contributors. Therefore, this review explores carbazole-based derivatives as possible drugs to treat Alzheimer's, diabetes, inflammation, cancer, and many more, along with their synthetic schemes, SARs, and activity.
View Article and Find Full Text PDFPiperonal-derived Schiff base molecules as potential multi-target therapeutic agents against Alzheimer's and diabetes.
Future Med Chem
August 2025
Third World Center for Science and Technology, H.E.J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, Pakistan.
Background: The dual burden of diabetes and Alzheimer's highlights the urgent need for multifunctional therapeutic agents. This study explores piperonal-derived Schiff base derivatives as potential dual-action enzyme inhibitors against -amylase (AA), -glucosidase (AG), acetylcholinesterase (AChE), and butyrylcholinesterase (BChE), offers a promising strategy for managing both conditions.
Methods: Schiff base derivatives of piperonal (heliotropin) were synthesized, structurally characterized, and explored against established drug targets of diabetes mellitus (DM) and Alzheimer's disease (AD).
Chuanxiong-Renshen medicine pair ameliorates neuroinflammation in Alzheimer's disease through modulation of the PKC-α/NF-κB signaling pathway.
Phytomedicine
August 2025
School of Basic Medical Sciences and Forensic Medicine, Hangzhou Medical College, Hangzhou, China. Electronic address:
Background And Aim: Previous studies have identified Chuanxiong Renshen decoction as a promising anti-Alzheimer's disease (AD) agent, with its brain-penetrating components characterized via UHPLC-MS/MS. This study further elucidates the anti-neuroinflammatory mechanisms of Chuanxiong-Renshen medicine pair (CRM) in AD.
Materials And Methods: 3 × Tg-AD mice were administered CRM for two months, and cognitive function was evaluated using novel object recognition (NOR) and Morris water maze (MWM) tests.
Computational insights and experimental breakthroughs in identifying next-generation acetylcholinesterase inhibitors.
Sci Rep
August 2025
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, M.S. Ramaiah University of Applied Sciences, Bengaluru, 560054, Karnataka, India.
The study aimed to identify the potential acetylcholinesterase (AChE) inhibitors for effective Alzheimer's treatment from existing FDA-approved drugs through a drug repurposing technique via computational tools. Further, to evaluate the anti-Alzheimer's potency of the identified drug with the help of a suitable drug delivery system through in vivo pharmacological studies. The molecular docking and dynamics simulation studies indicated that letrozole has a significant binding affinity of -9.
View Article and Find Full Text PDF